Literature DB >> 17681491

Stem cells as screening tools in drug discovery.

John D McNeish1.   

Abstract

All physiologic processes operate in a cellular setting. Therefore, drug discoverers need the highest quality cells as they pursue the next generation of safe and effective medicines. Recently, investigators have begun to consider stem cells as a new source of predictive, cell-based assays in drug discovery. Stem cell technology still has hurdles to overcome before these cells are fully accepted as decision-making reagents and amenable to high-throughput screening. However, with global research interest in stem cell biology, significant advances in the application of these cells in drug discovery have been reported. These advances are aligned with three important stages of pharmaceutical research: target discovery and validation, identification of efficacious chemical leads, and drug safety pharmacology. This concise review describes the application of stem cells in these areas of drug discovery with emphasis on molecular screening opportunities.

Mesh:

Year:  2007        PMID: 17681491     DOI: 10.1016/j.coph.2007.06.005

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  5 in total

Review 1.  Scalable stirred-suspension bioreactor culture of human pluripotent stem cells.

Authors:  Daniel E Kehoe; Donghui Jing; Lye T Lock; Emmanuel S Tzanakakis
Journal:  Tissue Eng Part A       Date:  2010-02       Impact factor: 3.845

2.  High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptors.

Authors:  John McNeish; Marsha Roach; John Hambor; Robert J Mather; Laura Weibley; John Lazzaro; Justin Gazard; Jacob Schwarz; Robert Volkmann; David Machacek; Steve Stice; Laura Zawadzke; Christopher O'Donnell; Raymond Hurst
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

3.  Drug discovery in Parkinson's disease-Update and developments in the use of cellular models.

Authors:  Gaia Skibinski; Steven Finkbeiner
Journal:  Int J High Throughput Screen       Date:  2011-06

4.  Reproducible culture and differentiation of mouse embryonic stem cells using an automated microwell platform.

Authors:  Waqar Hussain; Nathalie Moens; Farlan S Veraitch; Diana Hernandez; Chris Mason; Gary J Lye
Journal:  Biochem Eng J       Date:  2013-08-15       Impact factor: 3.978

5.  Development of a multiplexed microfluidic platform for the automated cultivation of embryonic stem cells.

Authors:  Marcel Reichen; Farlan Singh Veraitch; Nicolas Szita
Journal:  J Lab Autom       Date:  2013-08-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.